関節リウマチ:世界医薬品市場予測及び市場分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 13
1.2 List of Figures 18
2 Introduction 20
2.1 Catalyst 20
2.2 Upcoming Related Reports 21
3 Disease Overview 22
3.1 Etiology and Pathophysiology 22
3.1.1 Etiology 22
3.1.2 Pathophysiology 22
3.1.3 Prognosis 25
3.1.4 Quality of Life 25
3.2 Symptoms 26
4 Epidemiology 27
4.1 Risk Factors and Co-morbidities 27
4.1.1 Smoking is the only established lifestyle risk factor for RA 27
4.1.2 Genetics account for as much as 60% of RA cases 28
4.1.3 Half of RA deaths are attributed to cardiac-related conditions 28
4.2 Global Trends 28
4.3 Forecast Methodology 28
4.3.1 Sources used 29
4.3.2 Forecast assumptions and methods 30
4.4 Epidemiological Forecast 31
5 Disease Management 32
5.1 Treatment Overview 35
5.2 US 38
5.2.1 Diagnosis 38
5.2.2 Clinical Practice 38
5.3 France 40
5.3.1 Diagnosis 40
5.3.2 Clinical Practice 40
5.4 Germany 41
5.4.1 Diagnosis 41
5.4.2 Clinical Practice 41
5.5 Italy 42
5.5.1 Diagnosis 42
5.5.2 Clinical Practice 42
5.6 Spain 43
5.6.1 Diagnosis 43
5.6.2 Clinical Practice 43
5.7 UK 44
5.7.1 Diagnosis 44
5.7.2 Clinical Practice 44
5.8 Japan 46
5.8.1 Diagnosis 46
5.8.2 Clinical Practice 46
5.9 Australia 47
5.9.1 Diagnosis 47
5.9.2 Clinical Practice 47
5.10 China 48
5.10.1 Diagnosis 48
5.10.2 Clinical Practice 48
5.11 India 49
5.11.1 Diagnosis 49
5.11.2 Clinical Practice 49
6 Competitive Assessment 50
6.1 Overview 50
6.2 Strategic Competitor Assessment 50
6.3 Product Profiles – Major Brands 52
6.3.1 Enbrel (etanercept) 52
6.3.2 Humira (adalimumab) 58
6.3.3 Remicade (infliximab) 62
6.3.4 Simponi (golimumab) 67
6.3.5 Cimzia (certolizumab pegol) 72
6.3.6 Orencia (abatacept) 77
6.3.7 Actemra/RoActemra (tocilizumab) 82
6.3.8 Rituxan/MabThera (rituximab) 87
6.3.9 Methotrexate Sodium (numerous generic names) 91
6.3.10 DMARDs 95
7 Opportunity and Unmet Need 96
7.1 Overview 96
7.2 Unmet Needs 97
7.2.1 More rheumatologists in the field and physician knowledge of the disease 97
7.2.2 More cost-effective therapies through oral formulation and biosimilars 97
7.2.3 The development of predictive tests and discovery of biomarkers 97
7.2.4 The discovery of curative therapies 98
7.2.5 Improved drug safety and efficacy profiles 98
7.3 Gap Analysis 99
7.4 Opportunities 100
7.4.1 Predictive tools for diagnosis and treatment 100
7.4.2 Target specificity 100
8 Pipeline Assessment 101
8.1 Overview 101
8.2 Clinical Trial Mapping 102
8.2.1 Clinical Trials by Country 102
8.3 Clinical Trials by Phase and Trial Status 103
8.4 Promising Drugs in Clinical Development 105
8.4.1 Tofacitinib (CP-690550) 107
8.4.2 Fostamatinib (previously R788) 115
8.4.3 RAVAX 120
8.4.4 Secukinumab (AIN457) 124
8.4.5 Masitinib (AB101) 129
8.4.6 Baricitinib (formerly LY3009104/INCB28050) 134
8.4.7 Careram/KOLBET (iguratimod/T-614) 139
8.4.8 Sarilumab (REGN88/SAR153191) 142
8.4.9 Sirukumab (CNTO 136) 146
9 Current and Future Players 150
9.1 Overview 150
9.2 Trends in Corporate Strategy 152
9.3 Company Profiles 153
9.3.1 Abbott 153
9.3.2 Pfizer 155
9.3.3 Amgen 157
9.3.4 Johnson & Johnson 159
9.3.5 Eli Lilly 161
9.3.6 Bristol-Myers Squibb (BMS) 162
9.3.7 UCB 163
9.3.8 Roche 165
9.3.9 GlaxoSmithKline 167
10 Market Outlook 169
10.1 Global Markets 169
10.1.1 Forecast 169
10.1.2 Drivers and Barriers – Global Issues 172
10.2 United States 174
10.2.1 Forecast 174
10.2.2 Key Events 176
10.2.3 Drivers and Barriers 177
10.3 France 179
10.3.1 Forecast 179
10.3.2 Key Events 182
10.3.3 Drivers and Barriers 183
10.4 Germany 185
10.4.1 Forecast 185
10.4.2 Key Events 187
10.4.3 Drivers and Barriers 188
10.5 Italy 190
10.5.1 Forecast 190
10.5.2 Key Events 192
10.5.3 Drivers and Barriers 193
10.6 Spain 194
10.6.1 Forecast 194
10.6.2 Key Events 196
10.6.3 Drivers and Barriers 197
10.7 United Kingdom 198
10.7.1 Forecast 198
10.7.2 Key Events 200
10.7.3 Drivers and Barriers 201
10.8 Japan 203
10.8.1 Forecast 203
10.8.2 Key Events 206
10.8.3 Drivers and Barriers 206
10.9 Australia 209
10.9.1 Forecast 209
10.9.2 Key Events 211
10.9.3 Drivers and Barriers 212
10.10 China 213
10.10.1 Forecast 213
10.10.2 Key Events 215
10.10.3 Drivers and Barriers 215
10.11 India 217
10.11.1 Forecast 217
10.11.2 Key Events 219
10.11.3 Drivers and Barriers 220
11 Appendix 222
11.1 Abbreviations 222
11.2 Bibliography 225
11.3 Methodology 240
11.4 Forecasting Methodology 240
11.4.1 Diagnosed Rheumatoid Arthritis Patients 240
11.4.2 Percent Drug-treated Patients 241
11.4.3 Drugs Included in Each Therapeutic Class 241
11.4.4 Launch and Patent Expiry Dates 242
11.4.5 General Pricing Assumptions 243
11.4.6 Individual Drug Assumptions 244
11.4.7 Generic Erosion 250
11.4.8 Pricing of Pipeline agents 250
11.5 Physicians and Specialists Included in this Study 251
11.6 Primary Research – Prescriber Survey 252
11.7 About the Authors 253
11.7.1 Analysts 253
11.7.2 Global Head of Healthcare 254
11.8 About GlobalData 255
11.9 Contact Us 255
11.10 Disclaimer 255


【レポート販売概要】

■ タイトル:関節リウマチ:世界医薬品市場予測及び市場分析
■ 英文:PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update
■ 発行日:2013年2月27日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160464
■ 調査対象地域:グローバル
  • 蛋白質治療の世界市場2017-2021:mAbs、ヒトインスリン、凝固因子、EPO、ヒト成長ホルモン
    About Protein TherapeuticsTherapeutic proteins are used to effectively treat a wide array of diseases such as protein deficiency diseases; chronic diseases such as cancer, rheumatoid arthritis (RA), ankylosing spondylitis, diabetes; infections such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and hepatitis C; and other medical conditions such as genetic disorders, anemia cases …
  • 世界の位置情報基盤の検索・広告市場動向(2012-2016)
    TechNavio's analysts forecast the Global Location-based Search and Advertising market to grow at a CAGR of 49.49 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing use of location-based application-enabled mobile media. The Global Location-based Search and Advertising market has also been witnessing the increasing adoption of location-bas …
  • Rectal Cancer:グローバル臨床試験レビューH2, 2013
    Rectal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Rectal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rectal Cancer. It includes an overview of the trial numbers and their recruitment status as per the …
  • ポリスチレンの世界市場:用途及び地域別分析
    The report covers the important polystyrene global markets. It further divides the market on the basis of application and geography. The market data for these sub-markets have been provided with respect to volume (kilo tons) and value (USD Million). The global polystyrene market is projected to grow from $22,024.0 million in 2014 to $28,246.0 million by 2019, at a CAGR of 5.1% from 2014 to 2019. T …
  • 止血剤の世界市場:トロンビン、酸化再生セルロース、併用止血剤、ゼラチン、コラーゲン
    The global hemostats market is projected to reach USD 2.76 Billion by 2020 at a CAGR of 6.2% from 2015 to 2020. The Americas market contributed the largest share to the global market in 2014, wherein the U.S. dominating the Americas market. The report on global hemostats market analyzes and segments the market on the basis of product and region. It analyzes the competitive developments, such as al …
  • スマートグリッド市場レビュー:July 2013
    Smart Grid Review - July 2013 Summary GlobalData announces the release of its monthly smart grid newsletter for July 2013 from the Smart Grid eTrack. The newsletter provides update on the global developments related to smart grid deployment across the globe during the month of June 2013. Scope - Market prospect for companies providing smart grid systems - Key product launch in power grids - Major …
  • 世界の4WD(四輪駆動)及びADW(全輪駆動)小型車市場(2008-2028)
    This latest just-auto report edition offers a global review of the OE 4WD and AWD sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE 4WD and AWD market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospec …
  • 物理セキュリティ情報管理(PSIM)の世界市場2016-2020
    About Global Physical Security Information Management (PSIM) In the physical security market, the speed at which information is delivered is a critical element. Global PSIM deployments will increase rapidly as the solution enables faster transfer of critical information and easy access to information during emergencies. During public events, security operators should have fast and reliable access …
  • 主要先進国におけるHIV治療動向(~2019)
    HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth Summary The leading business intelligence provider GBI Research has released its latest research report, entitled,'HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations a …
  • 血液透析製品/サービスの世界市場2015-2019
    About hemodialysis Hemodialysis is a procedure in which excess fluids and toxins are mechanically filtered from the blood of individuals when the kidneys are not able to function normally. It is the treatment used when there is an acute and chronic disturbance in the functioning of the kidneys. It plays a major role in improving a patient's quality of life. For hemodialysis, vascular access is nee …
  • ミオクローヌス(Myoclonus)治療のグローバル臨床試験動向(2014年H2)
    Myoclonus Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Myoclonus Global Clinical Trials Review, H2, 2014" provides data on the Myoclonus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonus. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
  • 自動車産業向け炭素熱可塑性樹脂の世界市場予測(~2021)
    The global carbon thermoplastic market in automotive is projected to reach USD 549.4 Million by 2021, registering a CAGR of 29.65% between 2016 and 2021. Growth in production of automobile is increasing the demand for carbon thermoplastics market. Rising demand for fuel-efficient and light cars in developed and developing countries have triggered the growth of the carbon thermoplastics market. In …
  • 電気光学システム(レーザー、赤外線)のグローバル市場
    The report highlights and analyses the market drivers and restraints of the EO systems. The report also includes technology roadmap for EO systems. The geographic regions considered for the report are Asia-Pacific, North America, Middle East, Europe and rest of the world. The report analyses the trends and revenue of across these regions. Key countries from these regions are also analyzed. The seg …
  • リターナブル梱包の世界市場予測(~2023年)
    “Increased demand for returnable packaging from various end-use industries is expected to drive the overall growth of the returnable packaging market across the globe from 2018 to 2023.” The returnable packaging market is projected to grow from USD 37.9 billion in 2018 to USD 51.2 billion by 2023, at a CAGR of 6.2% during the forecast period. Growing demand for returnable packaging from various en …
  • スキンパック包装の世界市場2016-2020
    About Skin Packaging Skin packaging is used to package food products, consumer goods, and industrial goods. It is a type of carded packaging. In this packaging, the product that needs to be packaged is placed on a paperboard and is covered with a sheet of transparent plastic such as PVC or other plastic resins. The major end-users of skin packaging are the food, consumer goods, and industrial good …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。